|1.||Tundup, Smanla: 2 articles (01/2015 - 01/2013)|
|2.||Dhar, Shanta: 2 articles (01/2015 - 01/2013)|
|3.||Marrache, Sean: 2 articles (01/2015 - 01/2013)|
|4.||Harn, Donald A: 2 articles (01/2015 - 01/2013)|
|5.||Chen, Jincan: 2 articles (10/2014 - 01/2012)|
|6.||Zhou, Shanyong: 2 articles (10/2014 - 01/2012)|
|7.||Xu, Peng: 2 articles (10/2014 - 01/2012)|
|8.||Chen, Xueyuan: 2 articles (10/2014 - 01/2012)|
|9.||Xue, Jinping: 2 articles (10/2014 - 03/2013)|
|10.||Huang, Mingdong: 2 articles (10/2014 - 01/2012)|
|1.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
|2.||Breast Neoplasms (Breast Cancer)
03/05/2013 - "The primary subcellular localization of Zinc phthalocyanine and its cellular impact on viability, proliferation and structure of breast cancer cells (MCF-7)."
09/01/2001 - "Steady state fluorescence spectroscopy is used to study the binding characteristics of zinc phthalocyanine (ZnPc) to MCF-7 human breast cancer cells solubilized in a liposomal vesicle prepared with L-alpha-phosphatidic acid, dipalmitoyl. "
09/01/2001 - "The fluorescence study of the binding of zinc phthalocyanine to breast cancer cells solubilized in synthetic liposomes."
04/01/2014 - "Zinc phthalocyanine (ZnPcSmix) was used as the photosensitizer (PS) in this study to investigate the cell death patterns as a result of photodynamic therapy (PDT) in a breast cancer cell line (MCF-7) in vitro using a 680 nm diode laser at a fluence of 5 J/cm(2). "
01/01/2012 - "In this study, we conjugate a gonadotropin-releasing hormone (GnRH) to a photosensitizer, Zinc phthalocyanine (ZnPc), in order to enhance its specificity to breast cancer, which over-expresses GnRH receptor. "
01/01/2013 - "Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells."
08/01/2006 - "Zinc phthalocyanine/magnetic fluid complex: a promising dual nanostructured system for cancer treatment."
02/01/1995 - "Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size, and composition."
05/01/1993 - "Zn(II)-Phthalocyanine (Zn-Pc) is an exogenously administrable dye which is accumulated by tumors and other rapidly proliferating tissues. "
07/30/1992 - "Haematoporphyrin derivative is one of the main drugs currently used in clinical trials involving photodynamic therapy of cancer, and zinc phthalocyanine is being considered as one of several possible alternatives. "
|4.||Phototoxic Dermatitis (Phototoxicity)
01/01/2011 - "Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells."
01/30/1998 - "The phototoxicity of liposome-incorporated Zn(II)-phthalocyanine (ZnPc) and its water-soluble tetrasulphonated derivative (ZnPcTS) was studied in the tumorigenic but nonmetastatic (RE4) and the highly metastatic (4R) transformed rat embryo fibroblasts. "
08/01/1998 - "Phototoxicity of intra-tumoral injected methylene blue (MB+) was studied in 48 experimental colonic tumours in comparison with photosan-3, Zn-phthalocyanine and tetrasulphanated ClAl-phthalocyanine. "
04/01/2010 - "In this work the cell uptake and phototoxicity of the photosensitizer Zn(II)-phthalocyanine (ZnPc) in dipalmitoyl-phosphatidyl-choline liposomes have been studied in the presence or absence of inhibitors of macropinocytosis (cytochalasin D), and clathrin-mediated endocytosis (dynasore). "
|5.||Photosensitivity Disorders (Photodermatitis)
10/15/2001 - "Our studies on the photosensitization of 4R transformed fibroblasts with the second-generation photosensitizer zinc (II) phthalocyanine (ZnPc) aim at determining the effect of important experimental parameters such as time of cell incubation (2 or 24 h) with ZnPc before irradiation and ZnPc concentration in the incubation medium on cell death. "
04/01/2009 - "Photosensitization of SnO(2)/ZnO semiconductors with zinc-phthalocyanine."
10/15/2001 - "Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis."
01/30/1998 - "Photosensitization of cells with different metastatic potentials by liposome-delivered Zn(II)-phthalocyanine."
02/01/1997 - "In order to optimize the photosensitization of mitochondria, we prepared the new cationic zinc (II) phthalocyanines with lipophilic side-chains (2,9,16,23-tetrakis (trimethylammonio) zinc (II) phthalocyanine tetramethylsulphate (ZnPcA1) and 2,9,16,23-tetrakis(hexyldimethylammonio) zinc (II) phthalocyanine tetramethylsulphate (ZnPcA6)) and compared them with the known cationic lipophilic sensitizers 2,9,16,23-tetrakis[2-(trimethylammonio) ethoxy]zinc (II) phthalocyanine tetraiodide (ZnPcE1) and 2,9,16,23-tetrakis[2-(hexyldimethylammonio) ethoxy] zinc (II) phthalocyanine tetrabromide (ZnPcE6) and the anionic hydrophilic sulphonated sensitizer ZnPcS. "
|3.||LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
|4.||Phosphatidic Acids (Phosphatidic Acid)
|5.||Gonadotropin-Releasing Hormone (GnRH)
|6.||Adenocarcinoma of lung
|9.||Photosensitizing Agents (Photosensitizers)
|1.||Photochemotherapy (Photodynamic Therapy)
|4.||Bone Marrow Purging